Experts reassess endpoints, patient selection, targets, and timing for the development of successful immune-based treatments ...

The debate continues over the potential of measurable residual disease to transform research and clinical care in hematology.

The hematologic alterations occurred despite the ... In all subjects there were no remarkable changes in hematocrit, hemoglobin, red-cell count, mean corpuscular volume or hemoglobin concentration ...

Positive updates across all programs, including longer term efficacy and safety data from the HELIOS open-label extension trial of bitopertin in erythropoietic protoporphyria (EPP), additional ...

RECENT demonstrations by electron-microscopic 1–3 and epidemiologic methods 4 suggest that human acute leukemia is a viral disease. Experiments performed with mice with virus-induced leukemia ...

the frequency of hematological changes in COVID-19 patients, and their relevance in determining the prognosis of the disease, any particular pattern in hematological alterations in the initial ...

(NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that will change its name to BeOne Medicines Ltd., today announced it will share data across a range of hematologic malignancies ...

test more frequently if signs of hematological changes occur. Discontinue if neutropenia or TTP occur. Renal or hepatic impairment. Bleeding risk (eg, ulcers). Discontinue 10–14 days before surgery.